Indication:
- Treatment of uncomplicated malaria caused by Plasmodium falciparum, including multidrug-resistant strains.
- Used as part of Artemisinin-based Combination Therapy (ACT).
Dosage (typical 3-day regimen):
Adults and children ≥35 kg:
- One tablet OD*3/7
Pediatric dose (<35 kg):
- Dose is weight-based. Follow national malaria treatment guidelines or physician’s instructions
- Arterolane maleate: Equivalent to 150 mg of arterolane base
- Piperaquine phosphate: Equivalent to 750 mg of piperaquine base
- (Note: Pediatric tablets may be lower in strength)
- Take once daily for 3 consecutive days
- Take with water and preferably after food to improve absorption
- Do not skip doses; complete the full treatment course
- Avoid taking with other medications that affect heart rhythm
Arterolane:
- A synthetic trioxolane with fast parasite-killing action (similar to artemisinin)
- Produces reactive oxygen species that damage parasite proteins
- Rapid reduction of parasitemia
Piperaquine:
- A long-acting antimalarial from the 4-aminoquinoline group
- Inhibits heme detoxification, leading to parasite death
- Maintains therapeutic levels after arterolane is cleared to prevent recurrence
Combination effect:
- Arterolane clears parasites quickly
- Piperaquine provides post-treatment prophylaxis and prevents recrudescence
Common:
- Headache
- Dizziness
- Nausea, vomiting
- Abdominal pain
- Weakness (asthenia)
Serious (rare):
- QT interval prolongation (risk of cardiac arrhythmias)
- Allergic reactions
- Hepatotoxicity
- Known hypersensitivity to arterolane or piperaquine
- Congenital QT prolongation or history of cardiac arrhythmia
- Severe hepatic or renal impairment
- Concurrent use of QT-prolonging medications
- QT-prolonging drugs (e.g., macrolides, quinolones, antipsychotics): May increase risk of cardiac arrhythmias.
- CYP3A4 inhibitors/inducers: May alter piperaquine levels.
- Antimalarial drugs or other hepatotoxic agents: Increased risk of adverse effects.
Drug Status
Availability | |
Pregnancy | |
Breastfeeding | |
Schedule |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Synriam TM | 150mg/750mg | Tablet | 3’s | Sun Pharma | Sun Pharma |